BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/86/0.1/20.12.24 | Real-time Boerse Frankfurt Warrants 07:54:48 2024-07-02 EDT | ||
| 1.02 EUR | -3.77% |
|
| Current month | -14.52% | ||
| 1 month | +26.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-02 | 1.02 | -3.77% |
| 24-07-01 | 1.06 | -14.52% |
| 24-06-28 | 1.24 | -2.36% |
| 24-06-27 | 1.27 | +12.39% |
| 24-06-26 | 1.13 | +6.60% |
Real-time Boerse Frankfurt Warrants
Last update July 02, 2024 at 07:54 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD4LKR |
| ISIN | DE000VD4LKR1 |
| Date issued | 2024-04-19 |
| Strike | 86 $ |
| Maturity | 2024-12-20 (171 Days) |
| Parity | 10 : 1 |
| Emission price | 1.02 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.27 € |
|---|---|
| Lowest since issue | 0.81 € |
| Spread | 0.05 € |
| Spread % | 4.67% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.25
USD
Average target price
96.05
USD
Spread / Average Target
+6.43%
- Stock Market
- Warrants
- Warrant
